Novavax (NVAX) Q1 2024 Earnings
NVAX·Reported May 10, 2024·Before market open
Novavax reported Q1 2024 revenue of $93.9M, missed analyst consensus of $101.2M by $7.3M. Diluted EPS came in at $-1.05, missed the $-1.04 consensus by $0.01.
Revenue
$93.9Mmissed by $7.3M
Consensus: $101.2MDiluted EPS
$-1.05missed by $0.01
Consensus: $-1.04
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Novavax's Q1 2024 earnings report.
Novavax (NVAX) reported Q1 2024 earnings on May 10, 2024 before market open.
Novavax reported revenue of $93.9M and diluted EPS of $-1.05 for Q1 2024.
Revenue missed the consensus estimate of $101.2M by $7.3M. EPS missed the consensus estimate of $-1.04 by $0.01.
You can read the 10-Q periodic report (0001000694-24-000031) directly on SEC EDGAR. The filing index links above go to sec.gov.